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ABSTRACT
The neurotransmitter dopamine regulates chemosensory avoidance
behavior in the model organism Caenorhabditis elegans. Avoidance behaviors
are mediated by the polymodal ASH nociceptive sensory neurons, and
behavioral avoidance of stimuli detected by ASH is less robust when dopamine
signaling is impaired. We are investigating the neural response of the ASH
neurons to various stimuli; our investigation includes the behavioral and
physiological responses from the ASH neurons as dopamine signaling is
manipulated to better understand the effects of dopamine on these sensory
neurons. We hypothesize that dopamine plays a regulatory role on the ASH
neurons, lessening the response of the ASH neuron to noxious environmental
stimuli while the animal is in the presence of adequate food resources.
Behavioral assays revealed that cat-2 mutants, which are dopamine deficient,
had decreased behavioral response to the bitter tastant quinine compared to
wildtype animals. In addition, normal response to quinine was restored to cat-2
mutant animals in the presence of exogenous dopamine. Using a custom
microfluidics device and the transgenically-expressed Ca2+ sensor GFP variant
G-CaMP, we found that intracellular [Ca2+] changes in ASH neurons mirrors the
behavioral responses in wildtype and cat-2 mutants, and that exogenous
dopamine restores grossly normal response to cat-2 mutants. The dop-1 and
dop-4 dopamine receptor mutants had similar behavioral responses to quinine as
the cat-2 mutant while being resistant to exogenous dopamine. However, both
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the dop-1 and dop-4 receptor mutants showed increased Ca2+ influx in ASH
neurons when compared to wildtype animals. Collectively our data suggests that
dopamine plays a regulatory role on the ASH neurons.
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CHAPTER ONE:
INTRODUCTION

1.A. The Neurotransmitter Dopamine is a Monoamine with many Biological
Functions
Neurotransmitters are small organic molecules that are utilized by neurons
to transmit chemical signals between individual or groups of cells.
Neurotransmitters can be classified based upon the structure of the transmitter
molecule. The monoamine class of neurotransmitters includes dopamine,
serotonin, epinephrine, and norepinephrine; dopamine, epinephrine and
norepinephrine can further be categorized as catecholamines (Li et al., 2017).
The monoamine neurotransmitters are defined by their containing a single amine
group. Deficits in monoamine neurotransmitter signaling have been found to be
correlated with various ailments and diseases (Di Giovanni et al., 2016).

1.B. Dopamine Plays a Key Role in Several Neurological Diseases in Humans
Dopamine is known to play multiple critical roles within the human nervous
system. It is associated with the control of the locomotor actions, emotion,
cognition, sleep/wake cycles, and regulation of the neuroendocrine system
(Gugliandolo et al.; Korshunov et al., 2017; Oishi and Lazarus, 2017; Stoker et
al., 2017; Volkow et al., 2004).
1.B.1. Parkinson’s Disease and Dopamine
One important dopaminergic system in humans involves the dopamine
synthesizing region of the midbrain, the substantia nigra compacta. The
1

substantia nigra innervates the region known as the dorsal striatum, and this
pathway is collectively called the nigrostriatal pathway. It is associated with motor
control, and degeneration of this particular brain region results in Parkinson's
disease (Lang and Lozano, 1998; Vallone et al., 2000). The causes of
Parkinson’s disease remain unclear, though many possibilities are being
researched. Researchers are looking to genetics, harmful neurotoxins,
maladaptive biochemistry, and environmental factors as possible culprits leading
to Parkinson’s disease symptoms (Triarhou, 2013).
Parkinson’s disease is best characterized by the death of dopaminergic
neurons of the midbrain, reducing the amount of dopaminergic projections
connecting to the striatum. The decrease in dopamine within the system
manifests as a disruption of body movements; these disruptions appear as
hypokinesia, a decrease in the amplitude and frequency of voluntary movement,
or bradykinesia, a reduction in the overall speed of movement. In addition to the
locomotory deficits, Parkinson’s disease patients frequently suffer from sensory
neuron malfunctions manifesting as tingling and pain within the limbs (RodriguezOroz et al., 2009). Increased knowledge gained by research into the basic
biological functions of dopamine could aid in the future design of treatments for
individuals with Parkinson’s disease.
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1.B.2. Drug Addiction and the Role of Dopamine in the Mesolimbic Reward
Pathway
Drug abuse is a social concern costing the United States of America
billions of dollars a year in treatment, prevention, and law enforcement (Harwood
et al., 1984; Mark et al., 2001). Animal models have and will continue to be useful
tools in the ongoing quest to understand and thus treat the underlying biological
processes resulting in drug addiction (Engleman et al., 2016).
Dopamine plays an integral role in drug addiction (Chiara and Imperato,
1988; Volkow et al., 2004, 2009). Dopamine levels tend to be increased during
drug addiction. Both amphetamines and cocaine reportedly increase levels of
dopamine release in both the striatum and the nucleus accumbens by up to
tenfold and opiates are reported to increase levels of synaptic dopamine (Chiara
and Imperato, 1988).

1.C. Dopamine is Found in a Wide Range of Organisms
Dopamine is a conserved neurotransmitter and is utilized in a wide range
of organisms from relatively simple nematodes to more complex organisms such
as mammals. Some species of dinoflagellates utilize dopamine to regulate water
column migration in response to sunlight cues (Forward, 1977). Fruits and
vegetables utilize dopamine as a powerful antioxidant molecule to keep fruiting
bodies from browning (Udenfriend et al., 1959). Dopamine has even been
identified in interspecies interactions such as a host defense response to
infectious pathogens (Lyte and Ernst, 1993). Some wasps have been known to
3

inject dopamine into cockroaches in order to control the cockroaches’ behavior
so that the cockroaches do not respond to injected wasp larvae (Weisel-Eichler
et al., 1999). Infectious fungi utilize host produced dopamine in melanin
production in cases of meningitis infections (Williamson et al., 1998). Clearly
dopamine is a widely utilized molecule across a wide breadth of taxa.
1.C.1. Dopamine Biosynthesis
Dopamine is synthesized within the neurites (both dendritic and axonal) of
dopaminergic neurons from the amino acid precursor tyrosine. The rate limiting
step in the conversion reaction of tyrosine to dopamine is catalyzed by the
enzyme tyrosine hydroxylase. Tyrosine hydroxylase converts tyrosine to L-3,4dihydroxyphenylalanine (L-DOPA), which is then converted to dopamine by the
enzyme L-amino acid decarboxylase (Al-Baradie, 2002). The presence of the
gene coding for this tyrosine hydroxylase enzyme, encoded by the cat-2 gene in
C. elegans, has been used to define the presence of dopamine within a species
(Sulston et al., 1975; Vallone et al., 2000).
1.C.2. Signaling Through Dopamine Receptors
Most dopamine receptors are members of the seven-transmembrane
domain G-protein coupled receptors; other receptors such as ligand gated
chloride channels found in invertebrates can also be activated dopamine (Green
et al., 1996; Ringstad et al., 2009). To date, researchers have characterized five
unique DA receptors (Kerr and Wickens, 2001; Meador-Woodruff et al., 1992)
within mammals. Based upon pharmacological and biochemical attributes, they

4

have been classified into two main groups: the D1 type (D1 and D5) and D2 type
(D2, D3, and D4) receptors (Tarazi et al., 2001). Both receptor types contain
regions on the C-terminus that contain phosphorylation and palmitoylation sites,
which are thought to be involved in agonist-dependent desensitization of
receptors (Bates et al., 1991; Journot et al., 1987).
D1 and D2 receptors are frequently antagonistic to each other; this
antagonistic nature allows for the control of motor movements dopamine
signaling (Jorgensen, 2004). The D1 and D2 like receptors can achieve this
antagonistic regulatory relationship via the activation of different specific
intracellular targets. D1 receptors activate adenylyl cyclase, increasing levels of
cyclic AMP within the cell (Le Crom et al., 2003) which activates protein kinase A
(PKA). Within neurons, PKA is known to phosphorylate various proteins including
ion channels, and this alters their conductive properties and affects the
excitability of neurons. The D2 like receptors on the other hand are able to act
antagonistically to the D1 type receptors by negatively regulating cAMP levels via
inhibition of adenylyl cyclase (Beaulieu and Gainetdinov, 2011). For instance,
activation of D1 receptors leads to increased Ca2+ currents within the cell
(Missale et al., 1998).

1.D. C. elegans is an Ideal Model Organism for the Study of the Neuromodulatory Activities of Dopamine
Research into the basic biological functions of dopamine and dopamine
receptor activity is relevant in the treatment and understanding of the human
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conditions associated with dopamine activity. The study of basic function can be
carried be carried out in a multitude of organisms (See section 1C.). For this
study, we have chosen the model organism Caenorhabditis elegans for a variety
of reasons.
1.D.1. C. elegans is a Lab Model Organism with a Rapid Life Cycle
C. elegans is a small, free-living, soil inhabiting nematode worm that is a
well understood and widely used model organism within multiple research
subfields of biology, including neurobiology. C. elegans are mainly found as
hermaphrodites that produce both oocytes and sperm allowing for selffertilization; this aspect of the species allows for the maintenance of genetically
inbred lines (Brenner, 1974). Groups of C. elegans animals can be maintained on
small Petri dishes filled with agar and a bacterial food source; on these plates,
animals will develop through four larval stages (L1-L4) before becoming a
sexually reproducing adult. The maturation of C. elegans animals is dependent
upon the temperature of the environment ranging from three to five days (1525⁰C) (Blaxter, 2011; Byerly et al., 1976). Large numbers of C. elegans can be
maintained within the laboratory for minimal cost and effort (Engleman et al.,
2016; Sulston et al., 1975). One additional significant benefit to the use of C.
elegans as a model organism is that the animal is transparent, which allows for
easy imaging of internal structures in vivo (White et al., 1986) . As an
invertebrate and a nematode, experimental protocols are not subject to IAUAC
review processes.
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1.D.2. C. elegans has been Investigated with a Wealth of Genetic Tools
C. elegans can be genetically manipulated relatively easily by utilizing
ethyl methanosulphonate (EMS) as a random mutagen (Brenner, 1974),
producing libraries of mutants (White et al., 1986). C. elegans can also be
manipulated through reverse genetics, such as the addition of extrachromosomal
arrays via transgene injection into oocytes; these transgenic arrays can be
passed along to the progeny as semi-stable episomes (Mello et al., 1991).
Another reverse genetics tool that C. elegans can be investigated with is RNA
interference (RNAi). Injections of dsRNA into worms can selectively block the
activities of genes complimentary to the injected dsRNA (Gönczy et al., 2000;
Tabara, 1998). One of the newest tools for C. elegans reverse genetics is that of
CRISPR (clustered regularly interspaced short palindromic repeats) driven
recombination; this new procedure allows for the creation of both knock-ins
(addition of gene/function) and knock-outs (loss of function mutations) at
precisely engineered locations, allowing for editing of nearly any genomic region
of the species (Chen et al., 2013; Friedland et al., 2013; Gaj et al., 2013). Of
particular interest are the varieties of isolated mutant strains exhibiting behavioral
differences or aberrations when compared to wildtype worms. Mutations in single
genes that lead to differences in behavior illustrate the effect of genetics on the
behavior. This is particularly interesting as these mutations in single genes can
lead to an understanding of the molecular mechanisms of behavior.

7

1.D.3. C. elegans as a Model for Studying Drug Abuse
C. elegans has been used as a model to study the molecular and cellular
mechanisms underlying drugs of abuse, including that for alcohol (Wolf and
Heberlein, 2003), nicotine (Waggoner et al., 2000), cocaine (Musselman et al.,
2012), and methamphetamines (Schreiber and McIntire, 2011). Invertebrate
models offer the ability to relatively easily examine molecular frameworks of drug
addiction in a cost-effective way. C. elegans offers an array of well understood
behaviors to use in investigative assays ranging from egg laying to locomotor
gaits (Engleman et al., 2016). The C. elegans genome is completely sequenced
with approximately 19,000 protein coding genes, allowing for the study of basic
biological attributes of specific molecules. This study will utilize the cat-2 mutant
strain of C. elegans that is deficient in dopamine biosynthesis (Sanyal et al.,
2004) (See section 1.C.1), to aid in the investigation of the function of dopamine.
This mutant strain of C. elegans is especially useful due to the fact that in other
models, such as the in the common lab mouse Mus musculus, deficits in
dopamine production can be lethal during fetal development and so are of limited
use to researchers (Zhou et al., 1995).
1.D.4. C. elegans Utilizes Dopamine for Various Functions
Much has been determined about the functions of dopamine within the C.
elegans nervous system. Dopamine is believed to be released during times that
the animal is in the presence of an abundant food source; the increased release
of dopamine in turn make the animal more sensitive to aversive stimuli within the
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environment. The logic of this premise is such that animals in an environment
that is plentiful in food can afford to be more selective in food choice, avoiding
noxious substances, in comparison to an animal that is in a food poor
environment.

1.E. Dopamine Plays a Regulatory Role Over many Functions and Behaviors
1.E.1. Locomotion and Food Searching
Animals such as nematodes must locomote to survive. Locomotion is a
rich area of behavioral research and has offered many insights into the
neurobiology of C. elegans. Dopamine has been shown to play a role in multiple
C. elegans locomotory behaviors. C. elegans motor circuits do not function in a
deterministic process; instead, sensory inputs affect a continual repetitive series
of neuromuscular activities. In other words, animals do not “decide” on a given
locomotory path but instead have been shown to locomote in response to
environmental cues. Behaviors such as this are carried out via a chain of
neurons that can start with sensory neurons communicating with command
interneurons; these interneurons are able to elicit effects on motor neurons,
causing abrupt changes to direction of locomotion including the initiation of a
reversal, or the abrupt change of direction of locomotion. The command
interneurons retain some control over locomotion in animals which have had the
sensory neurons ablated, indicating the power these command interneurons
exhibit over neuromuscular activity. Studies of C. elegans on graded plates
(plates possessing a gradient of a given chemical that a worm may or may not
9

find attractive) have shown that the sensory neurons themselves are responsible
for the "mapping" of chemical stimuli in the animals’ environment (Sengupta and
Samuel, 2009).
An example of dopamine-driven behavior is the slowing of well-fed
animals when placed on a new food source; this basal slowing is enhanced if the
animals in question are not well-fed, indicating a likely role of dopamine signaling
in the regulation of this behavior. Animals deficient in dopamine did not exhibit
basal slowing; the basal slowing behavior was restored to that of wildtype
animals upon treatment with exogenous dopamine. Further, laser ablations of
dopaminergic neurons revealed that the multiple classes of C. elegans
dopaminergic neurons redundantly release dopamine during the activity of this
pathway. The data gathered in this experiment suggest a role of dopamine in the
control of basal slowing (Sawin et al., 2000; Suo et al., 2004).
Dopamine, in tandem with glutamate, is also known to be involved in the
regulation of the area-restricted search (ARS) behavior. This behavior is thought
to have evolved to keep animals around abundant food sources. ARS represents
an increase in turning rate in the presence of food allowing an animal to remain
in a food rich immediate environment. ARS patterns will vary with the time since
food was last encountered; the longer the amount of time since food was present
the less amount of turning behavior. It is thought that dopamine is released in the
presence of food to inhibit glutamate signaling, which in turn increases the
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amount of turning exhibited to maintain the animals in the location of food
sources (Hills et al., 2004; Vidal-Gadea and Pierce-Shimomura, 2012).
1.E.2. Gene Expression
Dopamine has also been found to affect gene regulation in C. elegans
through interactions with the transcriptional factor cAMP response element
binding protein (CREB) via G protein coupled receptors (GPCR); research has
shown implications of this regulatory pathway in learning and drug addiction.
Dopamine signaling through the D2-like dopamine receptors DOP-2 and DOP-3
has been found to inhibit release of octopamine (i.e. invertebrate norepinephrine)
upon exposure to environments containing adequate food resources. This
inhibition of octopamine release results in an inhibition of the CREB protein and
thus causes an effect on gene expression. Levels of dopamine within the C.
elegans nervous system track with levels of acetylcholine. Studies have shown
that in conditions of higher dopamine signaling resulted in lower acetylcholine
signaling. Upon addition of exogenous dopamine there is also an observable
decrease in acetylcholine release as well, supporting the idea that dopamine
influences acetylcholine release. This responsive change in neurotransmitter
release is slow as the changes depend upon the activity of CREB and CREB
being a transcription factor works slower than other signaling molecules. This is a
prime example of dopamine signaling affecting the signaling of another
neurotransmitter and in turn creating a change in gene expression via CREB
inactivation (Suo and Ishiura, 2013).
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1.F. Dopamine Receptor Activities Vary by Type
1.F.1. The DOP-1 and DOP-3 Receptors Frequently Function Antagonistically in
the Same Pathways
The D1-like and D2-like dopamine receptors (See section 1.C.2.)
frequently act antagonistically within the C. elegans nervous system. DOP-3, a
D2-like dopamine receptor, acts to slow the animals’ locomotion. DOP-1, a D1like dopamine receptor, acts directly antagonistically to the DOP-3 Gα0 signaling
pathway via the activation of the Gαq signaling, as well as the activation of PLCβ
signaling cascade. Both receptors have been found to be co-expressed within
cholinergic motor neurons as well as individually expressed in other neurons;
both receptor types appear to be expressed in levels high enough to effect
locomotion from within these cholinergic motor neurons (Chase et al., 2004).
DOP-3 acts via Gα0 to execute inhibitory signaling of locomotion within
ventral cord cholinergic motor neurons. The activation of the Gα0 signaling
pathway results in the inhibition of acetylcholine release, thereby lessening or
silencing the signals from the cholinergic motor neurons (Allen et al., 2011). The
activation of the Gαq signaling pathway results in the stimulation of acetylcholine
release. Thus, the release of dopamine into the C. elegans nervous system can
result in the animals’ ability to fine tune locomotory activities. Other similar
studies suggest that this antagonistic/regulatory relationship between the DOP3/DOP-1, D2-like/D1-like, dopamine receptors is conserved in mammals (Allen et
al., 2011; Chase et al., 2004). At the cellular level the system of control over
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locomotory function via co-expressed D1-like and D2-like dopamine receptors is
conserved in mammals within the medium spiny cholinergic neurons of the
striatum region of the central nervous system, although the precise location of
these receptors and thus the specific mode of activity during signaling remains
unknown in mammals (Allen et al., 2011).
DOP-1 and DOP-3 have also been implicated in C. elegans “choice”
making between aversive stimuli. This “choice” is defined as the animal’s
willingness to cross a barrier of diacetyl or Cu2+. They are thought to
antagonistically regulate behavioral choice via their respective targets. For this
particular behavioral choice pathway between aversive stimuli, the DOP-1
receptor is thought to function in cholinergic neurons and the DOP-3 receptor in
GABAergic neurons (Wang et al., 2014).
C. elegans naturally exhibit an increase in odorant sensitivity when
dopamine signaling is stimulated, such as in times of rich food resources are
present. While investigating the role of the various dopamine receptors in this
sensory pathway (Ezak and Ferkey, 2010), the dop-3 receptor mutant animals
are the only strain to exhibit a significant increase in the amount of time required
for response to 100% octanol. The data generated for the dop-3 mutant animals
suggests that the DOP-3 receptor is required for this enhanced sensitivity to
100% octanol. This activity has been exhibited both in vivo in the presence of
adequate food resources and in the presence of artificially increased exogenous
dopamine. The role of endogenous dopamine signaling in this pathway is
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supported by the phenotypic characteristics of the dopamine deficient cat-2
animals; the cat-2 animals do not exhibit the enhanced sensitivity to the octanol
stimulus in comparison to the wildtype control animals. DOP-3 expression as
assessed by transcriptional GFP reporter transgenes was not observed in either
of the sensory neurons ASH, ASI, or in any of the command interneurons.
However, transgenic expression of the DOP-3 receptor within the ASH neurons
was sufficient to modulate the animals’ response to aversive stimuli such as
octanol. These findings, in tandem with that of the cat-2 and dop-3 mutant
animals remaining hypersensitive to octanol exposure, suggest that dopamine
likely acts to dampen the signals from the chemosensory neurons themselves.
Cell specific RNAi knock-downs of the DOP-3 genes were created within the
ASH neurons using the ASH specific promoters osm-10 and sra-6; this resulted
in hypersensitivity to octanol that matched the behavior of the dop-3 mutants.
Data from this experiment further supports the idea that DOP-3 is naturally
expressed in the ASH neurons, and so is in position to modulate the animals’
responses to aversive stimuli. The fact that the DOP-3 receptors were not
observed to be expressed in the ASH neurons might be explained by the
technical limitations of C. elegans transgenic reporter genes. Interestingly, the
DOP-1 receptor does not play any antagonistic role within this octanol sensation
pathway (Ezak and Ferkey, 2010).

14

1.F.2. The DOP-2 Receptor is Associated with Various Homeostatic Functions
The DOP-2 receptor is known to negatively regulate various behaviors
including egg laying, locomotion, defecation and feeding. This had been
illustrated using DOP-2 antagonists to block dopamine signaling by DOP-2
receptors (Suo et al., 2004). Researchers have utilized yeast two-hybrid assays
to show that the DOP-2 receptor interacts with the Gαi subunit, GPA-14 which is
unique to C. elegans. The results support the idea that GPA-14 subunit in fact,
physically associates with the DOP-2 receptor and so likely acts in an inhibitory
fashion. Though no known homologs exist in mammals, the characteristics of this
GPA-14 subunit have been sufficient to describe the likely activities of this
subunit to be similar to the mammalian inhibitory G proteins (Pandey and
Harbinder, 2012).
Activated D2-like receptors are known to negatively regulate adenylyl
cyclase. D2-like receptors are known to negatively regulate Ca2+ currents via
interactions with Gαi/o subunits. This regulation is thought to in part have a
regulatory action on the biosynthesis of dopamine; some D2-like receptors are
found to be both pre- and post-synaptic, poised to regulate the activity of tyrosine
hydroxylase (See section 1.C.1), which is Ca2+ dependent (Suo et al., 2003). D2like receptors are also known to regulate K+ currents within the cell via
interactions with different G proteins (Jackson and Westlind-Danielsson, 1994).
D2-like receptors located on both pre and post synaptic neurons are able to elicit
the down regulation of cAMP levels (Suo et al., 2003).
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1.F.3. The DOP-4 Receptor is an Additional D1-like Receptor
The DOP-4 receptor is an analog to the DOP-1 receptor as it too is a D1like dopamine receptor. Interestingly, studies have indicated that the DOP-4
receptor is functionally active in the ASH neuron. Avoidance behavior to Cu2+
and glycerol in the dop-4 mutant strain is diminished in relation to wildtype
behavior; studies have shown that genetic rescues using either native promoters
or those that are ASH specific are adequate to restore the mutant behavior to
that of the wildtype animals (Ezcurra et al., 2011). Studies conducted on the
expression patterns of the DOP-4 receptors using GFP reporter fusion assays
indicate that the DOP-4 receptors are expressed in many head and sensory
neurons, but are not expressed in the ASH neurons (Sugiura et al., 2005). This
contradiction in expression patterns and functional patterns of the DOP-4
receptors creates an interesting topic for future research.

1.G. Dopaminergic Circuits within C. elegans
Dopamine has been shown to act synaptically and extra-synaptically
within the C. elegans nervous system. The aforementioned dopamine regulation
of cholinergic motor neurons is a prime example of this. These ventral cord
cholinergic motor neurons do not share synaptic connectivity with any of the
dopaminergic neurons within the C. elegans nervous system (Fig. 1). This lack of
connectivity indicates that dopamine must act on these neurons extrasynaptically or humorally as a neuro-hormone (Chase et al., 2004). The ASH
neurons do not share any direct synaptic connections with dopaminergic
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neurons; thus, if dopamine does play a regulatory role on the ASH neurons
themselves it might act in an extra-synaptic fashion, or dopamine might affect the
activity of the ASH neuron via connections with other neighboring neurons
(Ezcurra et al., 2011; Komuniecki et al., 2014).
1.G.1. C. elegans Dopaminergic Neurons
The C. elegans nervous system contains eight dopaminergic neurons. In
the head can be found a pair of ADE neurons, in the nose two pairs of CEP
neurons, and in body can be found a pair of PDE neurons (Fig. 1) (Bargmann,
2006; Sulston et al., 1975). C. elegans dopaminergic neurons are likely able to
sense bacterial food resources by direct mechanosensory perception (Kindt et
al., 2007; Sawin et al., 2000). Animals in the presence of food exhibit an
increased sensitivity to soluble repellents (See section 1.D.4.C.1.A.). This
behavior has been shown to be directly dependent upon the ability of
dopaminergic neurons to sense food in the immediate surrounding environment,
such as the ASH mediated behavioral response to aqueous Cu 2+ (Ezcurra et al.,
2011). This is an example of dopamine modulated behaviors related to the food
resource qualities in the environment.

1.H. C. elegans Expresses Multiple Sensory Neurons Dedicated to the Sensation
of Environmental Stimuli
The C. elegans hermaphroditic (See section 1.D.1) nervous system is
comprised of precisely 302 neurons. This relatively small number of individual
neurons comprising the nervous system is a benefit to research as the location
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and connectivity of each neuron has been largely identified. C. elegans neurons
can be grouped into a total of 118 classes of neurons; 20 of the 302 neurons can
be classified as pharyngeal and the remaining 282 as somatic (Hall and Russell,
1991; Varshney et al., 2011; White et al., 1986).
Environmental nutritional conditions are a key influence on C. elegans
behavior (Komuniecki et al., 2014). For instance, in times of abundant food
supply C. elegans are known to be more sensitive in aversive stimuli such as the
heavy metal Cu2+ (Ezcurra et al., 2011). The N2 wildtype reference strain of C.
elegans is known to gather in clumps containing many animals when food is
limited in the environment, whereas more “social” strains will exhibit this behavior
when food is not limited (de Bono and Bargmann, 1998).
C. elegans have 16 pairs of sensory neurons. These neurons are found in
pairs and are classified by the following names: ASE, AWC, AWA, AWB, ASH,
ASI, ADF, ASG, ASJ, ASK, ADL, URX, AQR, PQR, PHA, and PHB. These
sensory neurons synapse on interneurons and undergo integration prior to
synapses with command interneurons, which elicit changes in locomotory
behavior directly (Bargmann, 2006; Komuniecki et al., 2014).
1.H.1. The Amphid Pore is the Nematode’s “Nose”
Many of the C. elegans neurons are located in the head, forming groups of
sensory neurons called sensilla. Two of these sensilla are relatively large and
form what are known as the amphid pores (Fig. 2), located on either lateral side
of the animal. Each amphid pore contains the ciliated endings of eight sensory
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neurons, one pair of which are the sensory neurons under investigation in this
study, the ASH neurons (White et al.,1986). Amphid neurons also contain
axonemal cilia, which are exposed to the external environment to aid in
sensation. The ASH neurons are known to contain such axonemal cilia (Kaplan
and Horvitz, 1993; White et al., 1986). One can imagine the frequently hostile
nature of the external environment faced by worms living in soil, such as infection
by pathogenic bacteria (Finlay, 1999; Kurz and Ewbank, 2000) or desiccation
(Chakrabortee et al., 2007; Erkut et al., 2013). C. elegans as a species may have
evolved this amphid pore structure to protect the delicate terminal receptors of
the sensory neurons.
This unique structure of the amphid pores suggest that the amphid
sensory neurons represent the major chemoreceptor neurons of the C. elegans
nervous system. Laser ablation of these amphid neurons, such as ASE or ASK
neurons, result in the inability of the animal to properly sense its native
environment (Calhoun et al., 2015; Troemel et al., 1995). There exists a similar
structure in the tail of the C. elegans worm known as the phasmid, which is also
associated with gathering sensory information from the environment (Hall and
Russell, 1991; White et al., 1986).
1.H.2. The ASH Neuron is a Polymodal Sensory Neuron that Drives Dopamine
Sensitive Behaviors
The bilaterally paired C. elegans ASH neurons exhibit diverse capabilities
of sensing aversive stimuli in the immediate environment as polymodal sensory
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neurons. This includes stimuli such as high osmolarity, nose touch, volatile
chemicals, bitter tastants, and feeding behaviors in social settings (Bargmann,
2006; Ezak and Ferkey, 2010). The ASH neurons function as both chemo- and
mechanosensory neurons similar to the vertebrate nociceptor neurons that are
associated with the perception of pain in the vertebrate system (Kaplan and
Horvitz, 1993). Through behavioral analysis, the ASH neurons are known to
sense the following noxious stimuli: Cu2+, SDS (detergent), glycerol, quinine,
octanol, and possibly others (Ezak and Ferkey, 2010; Hilliard et al., 2005).
1.H.3. ASH Connectivity/Receptors
The ASH neurons are known to express a multitude of GPCRs with a suite
of associated Gα subunits such as odr-3, gpa-3 (both expressed in large
amounts), gpa-1, -11, -13, -14, and -15 (Bargmann, 2006) (Fig. 2). The ASH
neurons are also known to have synaptic connections with the command
interneurons AVD, AVB, and AVA (White et al., 1986); these synaptic
connections allow for the ASH neurons to directly excite the command
interneurons, stimulating them via the release of neurotransmitters such as
glutamate and neuropeptides. This excitation of the command interneurons leads
to a change in locomotion in response to ASH-sensed stimuli (Hart et al., 1995;
Mellem et al., 2002).
1.H.4. ASH Neural Modulation
In food rich conditions the ASH neurons show an increased physiological
response, as a quantifiable transient increase in intracellular Ca2+ levels, to both
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Cu2+ and glycerol. In addition to an increase in the magnitude of physiological
response, the ASH neurons also show an increase in duration of increased
intracellular Ca2+ levels in comparison to Ca2+ levels in food poor conditions
(Ezcurra et al., 2011). Some ASH mediated behaviors have been shown to be
modulated by neuropeptide signaling in addition to dopamine signaling
(Komuniecki et al., 2014). Clearly food availability influences ASH mediated
behaviors and so we hypothesize that food availability affects the activity of the
ASH neurons themselves, likely via dopamine signaling.

1.I. Ca2+ is the Major Ion Responsible for the Depolarization of the Neurons in C.
elegans
Ca2+ is most likely the major ion responsible for the depolarization of
neurons within the C. elegans, as the C. elegans genome lacks gene sequences
for voltage gated Na+ channels. Ca2+ ions are associated with depolarization and
K+ ions with hyperpolarization of C. elegans neurons (Goodman et al., 1998).
Typically, upon stimulation of a sensory neuron, the activation of GPCRs in the
sensory cilia results in a signaling cascade that activates Ca2+ channels such as
the OSM-9 TRP channel found within the membranes of ASH neurons allowing
for an influx of Ca2+ ions (Feng et al., 2006; Kahn-Kirby and Bargmann, 2006;
Xiao and Xu, 2009) (Fig. 3). This property allows for the relatively easy
quantification of neural activity based upon transient changes in intracellular Ca 2+
concentration, thanks to the development of Ca2+ sensitive reporter molecules.
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1.I.1. C. elegans Neural Activity can be Measured Non-Invasively Using Ca2+Sensitive Fluorescent Reporter Proteins
For the investigation of the neural-modulatory activities of dopamine, we
will utilize a modified green florescent protein (GFP) reporter known as G-CaMP
(Fig. 4A) that changes fluorescence intensity with changing Ca2+ levels. G-CaMP
consists of a circularly permutated GFP that has been linked together by the
Ca2+-binding domain of calmodulin (Nakai et al., 2001). The calmodulin domain
has been inserted into the GFP molecule such that the native β-barrel
conformation is broken at low concentrations of Ca2+ (Fig. 4C); when Ca2+ levels
increase, such as when C. elegans neurons are activated, the calmodulin domain
changes conformation and reconstitutes the β-barrel of GFP. Thus, an increase
in fluorescence indicates an increase in intracellular Ca2+ levels (Fig. 4C). GCaMP can be selectively expressed in the ASH neurons (Fig. 4B) by using ASHspecific promoters, such as the promoters for the sra-6 or osm-10 genes; this
approach has been previously used to measure ASH neuronal activity in other
contexts (Guo et al., 2009; Hilliard et al., 2005; Tobin et al., 2002).

1.J. Microfluidics Devices Offer a Novel Means of Conducting Neuro-Physiologic
Studies on C. elegans Animals
Microfluidics is an example of a crossroads in scientific research.
Borrowing from the physics of fluid dynamics, biologists have adapted the use of
microfluidic apparatuses to investigate a wealth of biological questions.
Microfluidics can broadly be defined as an analytical approach that use fluid
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flows on a very small (micro) scale (Mukhopadhyay, 2009). Microfluidics has
been in use for some time in tissue engineering and single cell experiments. The
use of microfluidics is a useful tool that has allowed neuroscientists to observe
the activities of variety of in vivo neurons from a range of organisms, to better
understand the ways in which neural circuits work. Microfluidics devices allow for
a simple means of immobilizing small organisms such as C. elegans for in vivo
imaging of cellular activities (Mondal et al., 2012).
Many common microfluidics devices are manufactured by casting
polydimethylsiloxane (PDMS); the PDMS polymer is transparent, allowing for
microcopy applications. The PDMS polymer is also biologically inert providing a
non-interactive microenvironment, and PDMS is relatively inexpensive allowing
for the rapid production of large numbers of microfluidic devices in a short
amount of time (Mondal et al., 2012; Schrott et al., 2009).
In the past, elaborate protocols for the immobilization of worms had been
developed utilizing organic glues such as cyanoacrylic glue to attach worms to
microscope slides; though effective, these procedures are technically challenging
and require significant time investments per animal immobilized (Richmond,
2009). Another technique used over the years is patch clamp electro-physiologic
recordings, which is the gold standard for neurobiologists and in many respects
remains the standard. Yet, similar to the organic glue procedures, patch clamp
recordings require the difficult dissection of animals ~1mm in length and results
in the death of the animals being recorded (Goodman et al., 2012). The
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techniques for patch clamp recordings are challenging to master. Modern
research techniques are paving the way for the elimination of many difficult to
control variables that are associated with invasive means of measuring neuron
activity. Researchers have adapted microfluidics systems for the immobilization
and study of C. elegans animals. The recording chips developed for nematode
neurobiology allow for the immobilization of single worms, rapid and precise
chemical stimulation, and observations of behaviors in tandem with the precise
neural activities that drive them (Chronis et al., 2007). The use of microfluidics
devices allows for the immobilization and recording of animals quickly and noninvasively in a short amount of time.
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CHAPTER TWO:
MATERIALS AND METHODS

2.A. Animal Maintenance
C. elegans animals were grown using standard methods on 60 mm Petri
dishes containing general purpose nematode growth media (NGM) (agar,
peptone, cholesterol, 1M CaCl2, 1M MgSO4, 1M KPO4 buffer at pH=6.0). NGM is
applied to plates via a peristaltic pump at 10 mL/plate. Food is provided to the
animals via OP50 E. coli bacterial lawns, seeded onto the plates at 100 μL/plate.
Animals were incubated at a range of temperatures (15-25⁰C) over a range of
time (3-5 days) respectively (Sulston et al., 1975).
2.A.1 Mating Protocols
Male animals carrying transgenic arrays were created mating male N2
animals with array carrying hermaphrodites resulting in male animals that also
carried the array. These male array carrying animals were then mated to
homozygous dopamine receptor mutants, representing the parental generation of
this cross. F1 heterozygous progeny were selected for via the expression of the
G-CaMP array as any animals expressing the G-CaMP were heterozygous for
the given mutant gene; selected F1 individuals were singled and allowed to selffertilize to create F2 progeny. F2 individuals were genetically screened for the
presence of the given mutated gene using PCR (see below).
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2.B. C. elegans Genotyping Protocols
Worm lysates were obtained from individual animals or from entire plates
of worms. Plates of worms can be washed from the agar plates using worm lysis
buffer (50 mM KCl, 10 mM Tris-HCl pH 8.3, 2.5 mM MgCl2, 0.45% NP-40, 0.45%
Tween-20, 0.01% gelatin), pelleted in a microcentrifuge and aliquoted into PCR
tubes. PCR tubes containing live animals were placed in a -80⁰C freezer for ~10
minutes prior to the addition of proteinase K (10mg/mL stock solution). Complete
reactions were then placed into a benchtop thermocycler, incubated at 60⁰C for
60 minutes, and finished at 95⁰C for a period of 30 minutes to terminate all
enzymatic activity.
Each strain under investigation had DNA primers designed to aid in
genotyping each mutant allele. The specific primers can be found in Table 1. The
dopamine receptor mutant strains each carry a deletion mutation within the
receptor gene allowing for relatively straightforward genotyping. The PCR
reactions were as follows: 23 µL H2O, 3 µL 10X Taq buffer, 0.4 µL 10 mM dNTP
mix, 1 µL left primer, 0.5 µL right primer, 0.5 µL internal primer, 0.3 µL 25 mM
MgCl2, 0.3 µL Taq polymerase, and 1 µL worm lysate mix (sample DNA) for a 30
µL total reaction volume. Thermocycler conditions are as follows initial
denaturation at 94°C for 2 minutes, 35 cycles of the following sequence: 94°C
(30 seconds), 55°C (30 seconds), 72°C (30 seconds), and a finishing polish at
72°C for 10 minutes). Genotyping PCR products were identified via gel
electrophoresis. Standard reactions were run on a 1.5% agarose gel at 90 volts
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for ~90 minutes in the presence of 1X TAE buffer (1 mM EDTA, 40 mM Tris and
20 mM Glacial acetic acid). Completed gels were viewed under a UV light
source.
The mutation carried by the cat-2 animals is a single point mutation
requiring the use of restriction fragment length polymorphism (RFLP) to complete
a genotyping experiment. The mutation in the cat-2 (e1112) allele creates an
extra cleavage site for the DdeI restriction enzyme. This results in an extra DdeI
fragment in the cat-2 samples that is not present in the wildtype samples and
therefore a different RFLP pattern; we used the larger wildtype (651 base pair)
and cat-2 (616 base pair) fragments to identify cat-2 genotype. Restriction
enzyme reactions were designed as follows: 5.5 µL H2O, 2 µL 10X BSA, 2 µL
10X Buffer 3, 0.5 µL DdeI, and 10 µL of sample DNA as suggested by the
enzyme vendor. The DdeI reaction was run at 37°C for a period of 2 hours.
Products were run in an electrophoresis apparatus that was kept on ice to reduce
the temperature of the reaction. A 3% Metaphor gel was used to resolve closely
sized DNA fragments, allowing for the genotyping of cat-2 animals.

2.C. Behavioral Experiments
Behavior was characterized by utilizing an amended protocol from
previously published works (Hilliard et al., 2005). Experiments were carried out
on foodless NGM plates made to contain 3% less H2O than standard NGM
recipes to create drier plates that facilitated the absorption of the dopamine
solution. All animals used for experimentation were young adults raised on plates
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incubated at 20 or 25°C. 10 individuals were placed onto each plate and allowed
to acclimate for ~5 minutes. Animals were stimulated with aqueous chemicals
delivered via flame drawn micropipette tubes (1 MM, VWR International,
TW100F-4). Single drops of stimuli were delivered to the agar near the tail of a
forward locomoting animal. Capillary action carries the fluid to the animal’s nose
and the amphid pore (Fig. 5 and section 1.D.6). The time (latency) between
delivery of stimuli and the response of the animal (reversal of direction of
locomotion) was recorded. Each animal on each plate was only tested once.
Data is analyzed as the fraction of animals responding within 4 seconds over the
total number of animals tested.

2.D. Microfluidics Experiments
2.D.1. Strains
The following strains were used for this study: N2 (reference wildtype
strain), CX10979 kyEx2865 [sra-6::GCaMP3; ofm-1::GFP] (gift from S.
Chalasani, Salk Institute), CB1112 cat-2 (e1112), FG58 dop-4 (tm1392), LX636
dop-1(vs101). All strains except for CX10979 were obtained from the
Caenorhabditis Genetics Center (St. Paul, MN).
2.D.2. Microfluidics “Chip” Production
For our microfluidics experiments we utilized an AutoCAD file of the
olfactory chip designed by the Chronis lab (Chronis et al., 2007) (Fig. 6); we
received this file with much gratitude from Dr. S. Chalasani of the Salk Institute.
From this file we had produced a mask to be spincast into a mold by the
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Microfluidics Foundry at Stanford University. All future casting made of this mold
were conducted using Sylgard 184 silicone elastomer (Sigma-Aldrich 7610365EA); Sylgard 184 is a two-part elastomer utilizing a 1:10 ration of hardener to
elastomer. For our castings we used a 6.4g:64g mixture that was spread over the
mold placed within a 150 mm plastic petri dish. The fresh castings were placed in
a vacuum desiccator to remove bubbles then allowed to cure for approximately
48 hours. Cured elastomer castings were removed from the mold, scored using a
scalpel and individual “chips” were separated prior to punching hose ports using
a Harris uni-core tool (internal diameter of 0.75 mm, Fisher scientific
NC0711699). Completed chips were them adhered to microscope cover slips
(Sigma Aldrich CLS2975245) using a corona generator (Electro-Technic
Products, 12051A-10) for approximately two minutes at a distance of 1 cm.
Lastly, chip and glass were pressed together, and a piece of tape is applied to
apply pressure as well as protect chip surface until the time of use.
2.D.3. Design of Microfluidics Fluid Delivery System
Our microfluidics system requires the use of 5-50 mm syringes used as
fluid reservoirs, each connected to the microfluidics chip via small diameter
Tygon tubing (ID 0.02 in, OD 0.06 in), using male Luer lock to 0.25 -inch (length)
barb adaptors. The other end of each tubing is connected to the fluid ports on the
microfluidics chip itself using a small section of metallic tubing (New England
Small Tubing, I.D. 0.017 inch—O.D. 0.025 inch). The first reservoir syringe is
filled with M13 buffer (30 mM Tris-HCl pH 7.0, 100 mM NaCl, and 10 mM KCl)
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(Hart, 2006) and is used to move animals into the microfluidics chip; a three-way
Luer lock valve was added in line prior to port 1 on the recording chip (see Fig 6)
with a 5 mL syringe added to the third port of the valve. This valve could be set
three ways: (1) continuous between syringe and fluid reservoir, so that the
syringe can be loaded with buffer; (2) continuous between the syringe and chip
as a means to provide pressure or suction while loading worms; (3) continuous
between the chip and the fluid reservoir in recording mode. To load a worm, the
syringe was first filled with buffer. The tubing was removed from port 1 of the
recording chip, and gentle pressure from the syringe was used to place a drop of
liquid on an animal on a foodless NGM plate. Gentle suction was then used to
pick worm from plate and into the tubing. The tubing was then reattached onto
the recording chip at port 1 and gentle pressure was applied so that the worm
could be injected into the worm trap. Pressure from this syringe was also used to
eject worms from the recording chip post experiment into the waste fluid efflux
via the vacuum port. Another reservoir is also filled with M13 buffer, but prior to
reaching the chip the tubing meets a three-way solenoid valve (Warner
Instruments, Cat. Number 64-0175(SV1)) that can switch the flow of fluid from
one hose to another; this assembly is used as an “on/off” switch for the
presentation of stimuli to the animal. This general setup was devised by our lab
by a previous student, Trisha Turturro. I adapted her design to deliver our
dopamine treatment to animals within the microfluidics chip. Another reservoir is
again filled with M13 buffer to be exposed to the animal during rest periods. This
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rest phase buffer reservoir is also connected to an additional three-way solenoid
valve but attached in the reverse direction of flow as the switching reservoir. To
this second solenoid valve is also attached an additional reservoir filled with M13
buffer containing freshly added dopamine to treat animals prior to testing. The
final reservoir is filled with the stimulus chemical (e.g., quinine) and has a direct
connection to the microfluidics ship with no solenoid interruptions. Fluids were
pulled through the microfluidics chip utilizing the house vacuum system attached
via the same small diameter tubing used to deliver the fluids to the microfluidics
chip.
2.D.4. Microfluidics Chip Experimental Setup
Individual chips were checked for defects prior to being used for an
experiment. The protective tape was removed from the microfluidics chip and is
used to firmly attach the microfluidics chip slide to the stage of the fluorescence
microscope. Next the vacuum tubing is attached to the chip (port 2) and allowed
to pull air through the microfluids chip for 15-30 minutes. All tubing coming from
the fluid reservoirs were primed by pulling fluid through the tubing using a 5 mL
syringe. After the tubing was primed, they were individually attached to the chip
according to the patterns shown in figure 7. Prior to starting any recording
experiments the flow of fluid is established and switching between fluid streams
is robustly tested to ensure proper functioning prior to running any experiment.
Once this was completed a small amount of immersion oil is added to the
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underside of the microfluidics chip slide in preparation for the 60X oil immersion
objective lens used during recording experiments.
Experimental animals were grown on NGM plates incubated at 25⁰C.
Individual animals were removed from the NGM growth plate (containing food)
and transferred to an NGM plate containing no bacterial food and allowed to
crawl around for a few minutes to “clean” the animals of bacteria prior to
experiments. A single animal was loaded into the chip as described above. The
animal is allowed to acclimate to chip conditions for a period of 3 minutes total,
the last 60 seconds of which it is exposed to blue fluorescence light as the ASH
neuron is known to be sensitive to this wavelength of light; pre-exposure to the
fluorescent light is able to halt the ASH neuron’s sensitivity to the light exposure
(Hilliard et al., 2005). Experimental recordings were obtained using Nikon NIS
software and an Andor (model #: DR-328G-CO2-SIL) camera on a Nikon TU2000 microscope (600x total magnification) (Fig. 10A). Experimental traces were
timed as follows: during the first 20 seconds (t0 – t20) of the recording subject
animals were exposed to the M13 buffer solution to determine a baseline of
fluorescence; between t20 – t50 subject animals were exposed to the 50 mM
quinine-M13 stimulus solution for 30 sec; and finally, between t50 – t120 the
quinine stream is switched away and animals were again exposed to only the
M13 buffer solution. This method was utilized to determine the ASH response to
the stimulus in each strain of animals. We used the same general recording
procedure for the dopamine treatment experiments with the addition of a
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prefusion of 4mM dopamine-M13 solution during the first 2 minutes the animals
were in the microfluidics chip.
Experimental recordings were initially compiled using the NIS Elements
software using the NIS ND sequence acquisition function; this includes both data
collection and initial quantification. After each recording that data self-loads for
the time measurement function; prior to making this measurement a region of
interest (ROI) is added to focus the measurement on the area immediately
surrounding the neuron, eliminating external signal noise not created by the ASH
neuron. After running the time measurement function the collected data can be
exported to Microsoft Excel for further analysis. Data from Microsoft Excel
spreadsheets was then imported into Igor (Wavemetrics) for analysis of each
recording trace. The procedure was designed to baseline correct each trace,
determine the maximum fluorescence, the integral of the trace, the initial slope of
response, and the total time of activity. All data points were then transferred to
JMP (SAS) to determine the statistical significance of the results. Physiologic
experimental data were analyzed using the Student's t-test and one-way ANOVA
with Tukey-Kramer method to compare means; behavioral data were analyzed
using Student's t-test; significance was set at p<0.05.
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CHAPTER THREE:
RESULTS

3.A. Endogenous Dopamine Appears to Play a Role in Control of C. elegans
Nociceptive Behaviors
To determine the neural-modulatory role of dopamine in the C. elegans
chemosensory avoidance behavior, we assessed behavioral differences between
wildtype and the dopamine deficient cat-2 mutant strains (See section 1.C.1). We
tested a panel of known ASH-sensed soluble stimuli (See section 1.H.2.). When
a drop of liquid containing a noxious substance is applied to a forward moving C.
elegans animal it responds by a rapid reversal of direction. The data for
responses were quantified in two ways: (1) a response was scored if the animal
reverses direction within four seconds of being stimulated and is reported as a
percentage of animals responding and (2) the actual time elapsed was recorded
from presentation of stimuli to the beginning of a reversal of direction (Fig 5). In
most cases, wildtype animals will respond with a reversal in direction for nearly
all animals tested. Dopamine deficient cat-2 mutant animals were observed to be
less responsive to stimulation with glycerol and quinine in comparison to the
wildtype animals. Only 50% of cat-2 animals responded to the glycerol stimuli
compared to >75% of wildtype responding. A more robust difference was
observed with the quinine stimuli, resulting in <20% of cat-2 animals responding
compared to nearly 100% of wildtype animals responding. cat-2 animals
responded better than wildtype animals when presented with 0.1% Cu2+; >85%
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of cat-2 mutant animals responded more rapidly compared with only ~50% of
wildtype animals responding. In summary, we found that for most of the
repellents tested, the dopamine deficient cat-2 animals responded less to
aversive stimuli; an interesting result was the increased response of the cat-2
animals to the heavy metal Cu2+ in comparison to the wildtype animals. These
results suggest that dopamine signaling may play a role in regulating C. elegans
response to soluble aversive stimuli, although different stimuli may be regulated
different ways (Fig. 8).
To further confirm that the behavioral differences observed between the
wildtype animals and the cat-2 animals could be attributed to a deficiency in
dopamine, we asked whether exogenous dopamine could restore normal
behavior to cat-2 mutant animals. We repeated the previous behavioral
experiments but tested the animals in the presence of exogenous dopamine.
There was no significant effect of the dopamine treatment on wildtype animals.
The dopamine treatment yielded no significant difference in the behavior of the
wildtype animals. The response of the cat-2 animals in the presence of
exogenous dopamine was restored to the normal response observed with the
wildtype animals (Fig. 9); with the addition of dopamine, ~90% of cat-2 animals
responded to quinine. This led us to also evaluate response to quinine in dop-1
and dop-4 mutant animals. As expected, both dopamine receptor mutants had
poor responses to quinine; ~45% of dop-1 and ~55% of dop-4 animals
responded to quinine. Exogenous dopamine treatment of the dopamine receptor

35

mutants had no effect on response (Fig. 9). These results suggest that dopamine
is required for regulating quinine sensation. Also, these results show that
dopamine can be applied to C. elegans exogenously to replace the missing
endogenous dopamine, suggesting that dopamine may be functioning
extrasynaptically as a neuro-hormone rather than as a traditional synaptic
neurotransmitter. This is consistent with previous studies using volatile odors
detected by ASH neurons (Baidya et al., 2014).

3.B. Microfluidic Devices in Conjunction with G-CaMP Reporter Proteins Allow for
the Quantification of Ca2+ flux within C. elegans Neurons
To make a quantitative assessment of ASH neural activity in the C.
elegans animals, we used a transparent microfluidics device (See section 1.J.) to
immobilize the animals and to allow for the rapid application and removal of
stimuli; the effects of the stimuli were quantified using the G-CaMP calcium
reporter protein expressed in ASH neurons (See section 1.I.1.). The microfluidics
device is mounted on a fluorescent microscope to enable us to create video
recordings of the change in fluorescence signal upon stimulation of the animals.
The various aqueous solutions that will be delivered to the animal within the
microfluidics device are contained in a series of fluid reservoirs (Fig. 7 and 10).
The flow channels in the microfluidics chip are connected to these reservoirs via
small diameter tubing, allowing for the delivery of fluids to the animal being tested
(See section 2.D.). The microfluidics device is also connected to a vacuum
source, which drives fluid flow. The addition of small solenoid valves in-line
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between the reservoirs and the microfluidics device allows for the rapid and
precise switching of the fluids to which the animal is exposed. Animals at rest are
exposed to a saline buffer or possibly an experimental treatment (i.e. exogenous
dopamine) and activating a valve exposes the trapped animal to a stimulus. A
closer look at the microfluidics device reveals the architecture of the worm trap
that immobilizes the animal in such a way that the nose is exposed to the
channel carrying the switchable fluid stream (Fig 10C).
To determine the resolution of the G-CaMP reporter proteins in the
evaluation of neural physiology we performed a series of experiments with C.
elegans to develop a procedure to quantify the activity of the ASH neuron. For
physiological recording experiments, we have used a strain of worms that
expresses the transgenic G-CaMP reporter proteins within the ASH neurons in
an otherwise wildtype background using the sra-6 promoter (sra-6::G-CaMP). We
measured Ca2+ flux as a proxy for the physiological response of ASH neurons to
stimulation with 1M glycerol. The fluorescence trace shows the average values of
the ASH neurons physiologic activities (Fig. 11A). To normalize the data, we
averaged twenty seconds of fluorescent signal while the neuron is at rest to
represent a baseline of activity; all the data points for an individual video
recording are then normalized by this baseline value to show an increase in
fluorescence as a percentage. The normalized data are then averaged over
multiple recordings from individual animals (n > 10). During the first twenty
seconds of each recording the animals are exposed to saline solution only; next
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the animals are exposed to the stimulus for a period of ten seconds, and lastly
the animals are exposed to saline again (Fig. 11) this represents an entire data
collecting recording. In later experiments we adapted this procedure to allow for a
longer, 30 second, exposure to stimulus to further investigate the kinetics of the
ASH neuron’s activity.
Is there an observable difference in the physiological activity of the ASH
neuron associated with the level of endogenous dopamine within an individual
animal? By utilizing a strain carrying the transgene in a cat-2 background (cat-2;
sra-6::G-CaMP), we can further understand the effects of dopamine on the ASH
mediated behaviors (Fig. 12). The dopamine deficient cat-2 mutant strain is
known to produce ~40% less dopamine compared to wildtype animals (Sanyal et
al., 2004), The sra-6::G-CaMP animals responded to the glycerol with a ~150%
increase in normalized fluorescence intensity over the baseline (Fig 12A). cat-2
sra-6::G-CaMP animals responded to the glycerol stimulus with a ~145%
increase in normalized fluorescence signal, which was not significantly different
from the way that the sra-6::G-CaMP responded (Fig. 12B). This line of
experimentation failed to yield data indicating a significant difference in the peak
fluorescence, as determined by students t-test, in the ASH neuron response as
measured as Ca2+ flux in the presence or absence of endogenous dopamine.
However, the data does suggest that we have developed a means to quantify the
activity of the ASH neurons; our quantified ASH activity traces resemble those of
multiple published works (Chronis et al., 2007; Hilliard et al., 2005).
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3.C. Dopamine Activity is Diminished in the Presence of Salt
C. elegans exhibits a thrashing behavior when placed in water.
Interestingly the addition of dopamine to water will paralyze the animals
eliminating the thrashing behavior. This assay is known as swimming induced
paralysis (SWIP) (Hardaway et al., 2012; McDonald et al., 2007). We have
utilized this behavior to determine the activity of dopamine when suspended in
the isotonic saline buffer solution M13 (see Materials and Methods), as M13 is
used as the standard recording buffer and will therefore be used to deliver
dopamine to animals trapped within the microfluidics device in our proposed
experiments. We found that the biological ability of dopamine to render C.
elegans animals paralyzed is diminished when the dopamine is suspended in
M13. 4 mM dopamine dissolved in polished H2O can paralyze >50% of animals
within 3 minutes of application. The paralyzing effects of dopamine was
diminished when the dopamine was dissolved in M13. When the dopamine is
dissolved in the M13 the concentration of dopamine must be increased to 300
mM to induce the same level of paralysis as 4 mM dopamine in water (Fig. 13A).
We assessed what solutes within the M13 recording buffer are responsible for
the diminished activity of dopamine in this assay by individually testing each
component of the M13 buffer with dopamine and assessing paralysis. Our data
indicates that both KCl and NaCl have an adverse effect of the ability of
dopamine to render the animals paralyzed; in the presence of either salt nearly
zero animals were paralyzed. The Tris buffer had no effect on the activity of
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dopamine; nearly 100% of animals treated with dopamine and Tris buffer were
rendered paralyzed (Fig. 13B). The data generated from the SWIP assays have
given us a working concentration of dopamine (300 mM) to match the activity of 4
mM dopamine in water..

3.D. ASH Neuron Response to Quinine
Although we did not find any difference in ASH Ca2+ response between
wildtype and cat-2 mutants when using glycerol, we decided to test if we could
detect a difference using quinine instead, as behavioral response to quinine in
the drop assay exhibited the most robust difference between wildtype and cat-2
(Fig. 8) (See section 3.A.). We initially used 10 mM quinine as stimulus for Ca2+
recordings because this concentration provided robust responses in behavioral
experiments. However, stimulation with 10 mM quinine did not yield any
detectable response. To remedy this problem, we attempted experiments with
increasing concentrations of quinine. 50 mM quinine yielded results that we were
able to quantify and so this became our stimulus concentration for all future
recording experiments.
We measured transient changes in intracellular [Ca2+] in C. elegans ASH
sensory neurons in response to chemical stimuli quinine (See section 3.A.) For
each experimental condition we obtained recordings from 20 individuals. We
initially analyzed the recording traces to establish the intensity of response; after
many iterations of the experiment, it became clear that certain individuals simply
did not respond. One explanation for this is that animals not producing a
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response might be damaged/injured in the microfluidics chip loading process (but
see also Discussion). We chose to exclude these responses from our statistical
analysis, but we report fractions of animals responding. We set a threshold of
>20% increase in peak fluorescent signal to include a trace in the statistical
analysis. We then analyzed the traces to determine the following metrics (Fig.
14). The peak fluorescence of response was measured as the maximum
percentage increase in fluorescence signal over the established baseline resting
level. The total time of response was measured as the amount of time that the
fluorescence signal was greater than that of the pre-stimulus baseline. The
integral of the traces was measured as the area under the trace between
application of stimulus to when fluorescence level returns to pre-stimulus
baseline. The slope of the initial increase in fluorescence signal is measured as
the initial slope of response. We also measured the time elapsed from stimulus
initiation to the peak fluorescence as the time to peak. Prior to analysis the traces
were normalized to zero using the pre-stimulus rest period data points. These
metrics were used to evaluate the activity profiles of the ASH neurons.
We found that ASH neurons in wildtype animals (n=17/20) responded with
a significantly greater peak of fluorescence (111.3% ± 13.2 Δƒ⁄ƒ) in comparison
to cat-2 animals (n=7/20) (56.8% ± 16.6 Δƒ⁄ƒ) and the integrals of response
(34914.8 ± 5572.6 (Δƒ⁄ƒ)∙(seconds)) and (16339.4 ± 6985.6 (Δƒ⁄ƒ)∙(seconds))
respectively, as expected based on initial behavioral experiments. There was no
statistical difference between the ASH neurons total time of response, slope or
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time to peak fluorescence between wildtype (Fig. 15A and 16) and cat-2 (Fig.
15B and 16). Interestingly, the fraction of ASH neurons in wildtype and cat-2
animals responding to quinine in this experiment resembled the fraction of
animals of their respective genotypes that respond behaviorally (see section
3.A.). The data suggests that endogenous dopamine signaling affects the overall
magnitude of Ca2+ flux in ASH neurons in response to quinine without changing
the overall kinetics.

3.E. Exogenous Dopamine Restores Normal ASH Response of cat-2 Animals
We next tested the ASH response of dopamine treated animals for
comparison with non-treated animals. SWIP assay data (see section 3.C.)
indicated the need to greatly increase the concentration of dopamine to maintain
physiologic functions in the M13 buffer solution. However, early experiments
using the 300 mM dopamine-M13 solution gave rise to technical problems.
Usually in a typical recording experiment, we are able to process several animals
allowing for the acquisition of several traces using a single microfluidics chip.
Individual animals are injected into the microfluidics chip, tested, and then
expelled using syringe to push the worm out of the trap and eventually into the
vacuum (port 2); a second worm can be then loaded and the process repeated.
Using 300 mM dopamine we were only able to test a single animal per
microfluidics chip, as each animal became stuck just outside of the trap never
arriving at the vacuum port. We believe the excess dopamine created a more
viscous solution not allowing for the ejection of the tested animal. We also
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viewed this dramatically increased concentration of dopamine as unrelatable to
the significantly lower concentrations of 4 mM used in behavioral assays. To
remedy problems of viscosity and of potential unrealistic dopamine
concentrations, we decided to attempt treatment with the 4 mM concentration of
dopamine-M13 solution, even though 4 mM M13 showed little activity in the
SWIP assay. We knew from the previous SWIP assays that the stability of the
dopamine in the M13 buffer declined over time, but would it remain stable
enough over the short term to allow for treatment of animals? To ensure that
each dopamine treatment had equivalent effects we created the 4 mM dopamine
M13 solution immediately prior to each experimental trail and completely flushed
the previous treatment mixture from the system prior to proceeding with the next
trial. This was a time-consuming process but much more efficient that the
experimental trials with the 300 mM dopamine M13 solutions. Exogenous
dopamine was perfused within the microfluidics recording rig for a period of 60
seconds prior to running the before mentioned experimental recording procedure.
As seen in figures 15B and 16A, 4 mM dopamine treated cat-2 animal ASH
neurons (n=9/20) responded with a significantly greater peak fluorescence
(263.0% ± 55.5 Δƒ⁄ƒ) when compared to non-treated cat-2 animals (Fig. 15D and
16A) ASH responses (n=7/20) (56.8% ± 16.6 Δƒ⁄ƒ). We also observed a
significant difference in the integral of the ASH response traces when comparing
the dopamine treated cat-2 animals (79868.8 ± 17891.6 (Δƒ⁄ƒ)∙(seconds)) with
the non-treated cat-2 animals (16339.4 ± 20287.1 (Δƒ⁄ƒ)∙(seconds)): a ~480%

43

increase (Fig. 16C). We observed no significant difference in the comparison of
the following metrics: total time of response, slope, or time to peak fluorescence
as seen in figures 16. We continued with the 4 mM dopamine treatment of
wildtype animals. Comparing dopamine treated (n=13/20 ) (193.9% ± 39.49 Δƒ⁄ƒ)
versus non-treated (17/20) (104.2% ± 41.1 Δƒ⁄ƒ) wildtype animals (Fig 15A,C
and 16A), ASH responses to 50 mM quinine revealed a wider variance in
response but not a statistically significant difference in the means. Again, we
observed no significant difference in any of our comparative metrics as seen in
figure 16. This data suggests that exogenous dopamine treatment partially
restores normal ASH activity in dopamine deficient cat-2 animals.
We next compared 4 mM exogenous dopamine treated wildtype and cat-2
animals. We observed no significant differences in the peak fluorescence, total
time of response, the integral, slope or time to peak between wildtype and cat-2
ASH neurons as seen in figure 16. Interestingly, the OFF response in dopaminetreated cat-2 animals was greatly increased. These data further suggest that
endogenous dopamine influences ASH neuron activity in response to quinine,
although the exogenous dopamine treatment of dopamine deficient cat-2 mutants
does not fully recapitulate the wildtype response.

3.F. ASH Neurons in DOP Receptor Mutants Respond to Quinine more Robustly
than Wildtype Animals
With good evidence supporting the hypothesis that dopamine plays a
regulatory role on the ASH neuron activity we further desired to understand what
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dopamine receptors may be at play in this regulatory pathway. As previously
discussed, good candidate dopamine receptors for investigation are dop-1 and
dop-4 (See section 1.F.). We recorded ASH Ca2+ response traces to 50 mM
quinine for both dop-1 and dop-4 mutant strains of C. elegans animals. We first
compared the ASH response curves between dop-4 mutant animals (Fig. 15F)
with that of wildtype animals (Fig. 15A). The ASH response trace of dop-4
animals (n=17/20) showed no significant differences in the metrics of peak
flouirescence, slope, integral of response, total time of response or the time to
peak fluorescence when compared to wildtype animals as seen in figure 16. We
also observed significant differences in peak fluorescence between dop-1
animals (Fig. 15E) (n=19/20) (556.1% ± 69.5 Δƒ⁄ƒ) and wildtype animals (Fig.
15A) (n=17/20) (104.1% ± 87.5 Δƒ⁄ƒ) (Fig. 16A). This difference was massive - a
greater than a 4-fold increase.. Next, we observed a significant difference in the
integral of the curves between dop-1 animals (168447 ± 29128.9
(Δƒ⁄ƒ)∙(seconds)) and wildtype animals (34915 ± 38282.9 (Δƒ⁄ƒ)∙(seconds)) (Fig.
16C); the dop-1 ASH response had a ~480% increase in the integral compared
to wildtype animals. Additionally, we observed a significant difference in the initial
slopes of the curves comparing dop-1 animals (44.1 (Δƒ/ƒ)⁄(sec.) ± 10.0) and
wildtype animals (9.1 (Δƒ/ƒ)⁄(sec.) ± 12.6) (Fig. D). Lastly, we observed a
significant difference in the time to peak fluorescence between dop-1 (24.7 ± 2.3
seconds) animals and wildtype (24.5 ± 2.9 seconds) animals as seen in figure
16. Finally we compared the ASH response profiles to 50 mM quinine between
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dop-1 (Fig. 15E) (n=19/20) and dop-4 (Fig. 16F) (n=17/20) mutant animals. We
observed a significant difference while comparing the peak fluorescence of dop-1
animals (556.1% ± 72.0 Δƒ⁄ƒ) and dop-4 animals (314.5% ± 79.1 Δƒ⁄ƒ) (Fig.
16A). We found no additional significant difference in any of the remaining
metrics of total time of response, the integral of the curves, the initial slopes of
the curves, or the time to peak fluorescence comparing dop-1 animals to dop-4
animals as seen in figure 16. Contrary to our initial expectations these data
suggest the DOP receptor mutants have a more robust Ca2+ response in ASH
neurons than wildtype animals, discussed further below.
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CHAPTER FOUR:
DISCUSSION
The experiments described above in Chapter 3 strongly suggest that
dopamine influences the response of the ASH neurons to the noxious stimuli
quinine. Behavioral experiments revealed significant differences in the behavior
of C. elegans animals with different levels of endogenous dopamine; treatment of
dopamine deficient cat-2 mutants with exogenous dopamine restored behaviors
to resemble those of normal animals (Fig. 7). ASH neurons are known to detect
noxious environmental stimuli such as quinine (Bargmann, 2006; Ezak and
Ferkey, 2010), yet the question remains as whether dopamine influences the
activity of the ASH neurons causing the behavioral differences observed. In
physiological experiments utilizing the G-CaMP fluorescent reporter to provide a
Ca2+ flux trace as a proxy for neural activity, we were able to demonstrate that
treatment with exogenous dopamine restored the Ca2+ activity of the ASH
neurons in cat-2 dopamine deficient animals to that of wildtype animals (Fig. 15C
and 16).
Early behavioral experiments within our lab revealed that M13 recording
buffer substantially reduced the activity of dopamine. SWIP assay data (see
section 3.C) suggested that the ability of dopamine to render the animals
paralyzed was greatly diminished at standard 4 mM concentrations in the
presence of the M13 recording solution. To get around this problem, we asked
whether greater concentrations of dopamine in the M13 buffer could elicit the
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same effects observed with lower concentrations of dopamine in H2O;
experiments revealed that 300 mM dopamine in M13 had the same paralytic
effects as 4 mM dopamine in water. With this new “working” combination of
dopamine and M13 buffer we attempted to treat animals within the microfluidics
chip, but this approach proved to be problematic. Experimental throughput was
severely impacted as only one animal was able to be processed through each
microfluidic chip after which the chip became unusable, requiring a timeconsuming switching and preparation of microfluidics chips in between trials.
Something about this high concentration of dopamine was causing animals to
become stuck within the microfluidics chip; we hypothesized that the solution had
become more viscous or sticky causing the animals to become stuck. We also
hypothesized that the paralytic effect of the dopamine may play a role in
preventing the animals from being ejected from the microfluidics chip.
This left us in a predicament; we desired to treat the animals with
dopamine inside of the microfluidics chip, but to maintain separation of fluid flows
within the microfluidics chip as well as to maintain similar osmotic concentrations,
the dopamine had to be delivered in the M13 solution. The SWIP assay
presumably targets ventral cord motor neurons that are known to express
dopamine receptors (Hardaway et al., 2012; McDonald et al., 2007). Previous
experiments showed that lower concentrations of dopamine in M13 could
influence ASH driven behavior (see section 3.A.) (Ezak and Ferkey, 2010), which
are done on NGM plates that contain similar salt concentrations as M13 buffer.
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The ASH neurons are also amphid neurons (see section 1.D.6.) with sensilla that
are directly exposed to the microfluidic buffer stream, as opposed to the ventral
cord motor neurons that are located more posteriorly and therefore "shielded" by
the PDMS chip. If dopamine receptors are expressed in ASH, it is possible they
would be more accessible to dopamine in the buffer stream even at lower
effective concentrations. Given these considerations, we attempted to use lower
concentrations of dopamine in M13 in our recording chip to see if we could
observe any effects. This approach allowed for successful exogenous dopamine
treatments in the microfluidics chip, providing data that clearly and significantly
illustrated the effect of dopamine on the ASH neurons (see section 3.E).
We observed some differences between our ASH Ca2+ recordings and
similar previously published data. As discussed in section 1.H. the ASH neurons
exhibit a peak of activity at the onset (the ON response) of stimulus that rapidly
decays but does not return to baseline; the neuron shows a steady and elevated
level of Ca2+ until the stimulus is removed. The removal of the noxious stimuli
triggers an OFF response, which is characterized by another spike in intracellular
Ca2+ followed by a rapid drop-off back to baseline (Chronis et al., 2007; Hilliard et
al., 2005). This ON/OFF response was characterized using glycerol (i.e.,
hyperosmotic shock) as a stimulus for ASH neurons. ASH neurons were also
shown to have a Ca2+ response to quinine (Hilliard et al., 2005), although an
ON/OFF response was not observed in that study. Overall, the recordings we
obtained using quinine were grossly similar to published results. Our ASH traces
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of both wildtype and cat-2 animals had the marked ON and OFF response peaks
to application and removal of quinine but the ON response was more persistent
and did not decay as quickly. The amplitude of our Ca2+ peaks (~80% increase)
were also lower than reported values for ASH neurons (~180% increase).
There might be several explanations for these discrepancies. In Hillard et
al (2005) a different Ca2+ sensitive reporter protein cameleon was used to
measure quinine responses. Cameleon uses a different mechanism for Ca 2+
induced fluorescence than G-CaMP (Looger and Griesbeck, 2012). Furthermore,
cameleon reporters are sensitive to motion artifacts, and worms are physically
glued to an agar pad to facilitate recording; this may have affected ASH neurons
in some way that obscured an ON/OFF response. We adapted the microfluidics
chip approach that Chronis et al (2007) used and saw a similar ON/OFF
response for quinine as they did for glycerol, suggesting that an ON/OFF
response is a general feature of ASH neurons. The differences in the decay of
the ON response might be attributable simply to differences in stimuli (glycerol vs
quinine). Finally, although we used (from a behavioral standpoint) a very strong
stimulus of 50 mM quinine, the amplitude of the Ca2+ spike was relatively weaker
than previously reported for ASH neurons. We note that our preliminary
experiments with glycerol were also substantially weaker than published results
(Fig. 12) and we did not observe ON/OFF responses with glycerol treatment
even using the microfluidics chip. It is possible that local environmental
conditions in our lab simply yield weaker ASH responses in general.
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Our data suggests that treatment of dopamine deficient cat-2 with
exogenous dopamine can increase the overall activity of the ASH neuron in
response to the noxious stimulus quinine; this increase in activity grossly
resembles that of the ASH activity of exogenous dopamine treated wildtype
animals (Fig. 15). Similar to published works we saw a near doubling in the
amplitude of exogenous dopamine treated wildtype animals in comparison to
non-treated animals (Ezcurra et al., 2011) (Fig. 15). That exogenous dopamine
can increase Ca2+ activity in wild type animals is not surprising, given that it takes
at least 5 minutes to load an animal into the microfluidics chip, during which it is
not exposed to food. cat-2 ASH activity was increased to a similar peak and
overall general activity as wildtype; this represents a nearly 400% increase in
comparison to non-treated cat-2 ASH activity. In addition, ASH activity observed
in dopamine treated cat-2 animals had grossly exaggerated OFF responses
when compared to the ON response. This was evident when comparing our
wildtype results or with other published data (Chronis et al., 2007; Hilliard et al.,
2005). Even though we do not see the same OFF response increase in wildtype
animals, we also do not see the same percentage increase in overall ASH
activity; this indicates that the exogenous dopamine treatment had a stronger
effect on ASH activity in cat-2 mutant animals. It is therefore reasonable to
conclude that exogenous dopamine treatment largely restores normal ASH
neuron Ca2+ response to quinine in cat-2 mutants, and that the differences
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between cat-2 and wild type ASH neuron Ca2+ responses can be attributed to a
dopamine deficiency.
Interestingly, when we tallied the percentage of animals responding with
increased ASH Ca2+ activity in relation to quinine stimulation, we observed that
the data closely resembled that of the behavioral data; nearly all wildtype animals
responded in both behavioral and physiological experiments whereas less than
half of cat-2 animals responded. This trend continued as we treated the animals
(both cat-2 and wildtype animals) with exogenous dopamine. These results may
indicate that although we observed an increase in the Ca 2+ activity of the cat-2
ASH neurons, this does not necessarily mean that this would in fact elicit a
change in behavioral response. A trivial explanation for this observation is that
the fraction of animals responding in the Ca2+ recordings is just an artifact
caused by experimenter handling; this is possible, but we do not think this is the
case. One possible explanation is the exogeneous dopamine we added may
have restored Ca2+ flux amplitude but not probability of firing in ASH neurons. In
such a scenario, exogenous dopamine would also have to activate other sensory
neurons to detect quinine when ASH does not fire. C. elegans alters the sensory
neurons used to detect volatile chemical repellants depending on serotonin levels
(Chao et al., 2004), so this is not without precedent. Also, the ASK neurons are
also known to be quinine sensing neurons (Hilliard et al., 2004). This implicitly
suggests that dopamine must have multiple cellular sites of action; it is therefore
useful to consider dopamine receptors.
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Both dop-1 and dop-4 mutant strains were shown to respond to the
quinine stimulus less frequently than wildtype animals in behavioral assays (See
section 3.A.). Unlike cat-2, both mutant strains responded reliably in Ca2+
recordings (about 7-9 responses vs. 17-19 responses per 20 trials, respectively).
Much to our surprise, the dopamine receptor mutants had far more robust Ca 2+
responses, showing a ~250-400% increase in ASH activity in comparison to
wildtype animals. The Ca2+ recording data suggests a down-regulatory role for
dopamine receptors in the activity of the ASH neurons in response to quinine
stimulation; but the behavioral results suggest that these dopamine receptors upregulate ASH-mediated aversive behaviors (See section 1.H.2. & 3.A.). In other
words, an increase in the activity of the ASH neurons does not necessarily
equate to an increase in aversive behaviors.
The idea that dopamine might have multiple cellular sites of action is
consistent with this discrepancy we observed in the dop-1 and dop-4 mutants.
For instance, dopamine might dampen ASH activity, but dopamine might also
activate other downstream neurons that promote behavioral output. In this
scenario, deleting the dopamine receptors would result in a net decrease of
behavioral output because of a downstream bottleneck, even though ASH Ca2+
activity is increased. Alternatively, Ca2+ activity in ASH neurons does not directly
correlate with behavioral output. In this scenario, dopamine receptors also
dampen ASH activity, but large increases in intracellular Ca2+ actually result in
less neural output. For instance, ASH neurons also use neuropeptides as
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neurotransmitters, and neuropeptides usually are released with increased
presynaptic activity (Ezcurra et al., 2016). Admittedly, all this is difficult to
reconcile with these results and those of the cat-2 mutants with exogenous
dopamine treatment.
As shown, our experiments support the hypothesis that dopamine plays a
regulatory role on the ASH neurons, but a there does not appear to be a simple
model that is consistent with all our data. Further understanding of this sensorybehavioral network could possible shed light on the complex activities of
dopamine signaling. Investigation of the other neurons in communication with the
ASH neurons could provide insight into dopamine regulation outside of the ASH
neurons themselves. We could first use a series of transgenes expressing
dsRNA targeted against unc-13 using cell specific promoters. unc-13 codes for a
protein associated with stabilizing other pre-synaptic vesicle docking proteins
(Richmond and Broadie, 2002) and knocking down unc-13 activity by RNAi would
block synaptic transmission(Grishok et al., 2005). By blocking synaptic
transmission, the unc-13 mutation would allow for the systematic silencing of
individual neurons that might regulate ASH. Using our new understanding of the
activity of ASH in regard to dopamine sensitivity and detection of quinine, both in
terms of behavior and Ca2+ response, we could identify neurons in which lack of
synaptic transmission would alter ASH Ca2+ response patterns. For instance,
ADL sensory neurons receive synaptic input from the CEPV dopaminergic
neurons and send synaptic output to ASH neurons (Fig. 1). Knocking down unc-
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13 activity in CEPV or ADL might show if those connections are relevant in
dopamine modulation of quinine response. Experiments such as this could help
us understand the cellular location(s) of dopamine activity and regulation.
We still do not have a clear understanding of the dopamine receptor
expression patterns. Based on functional studies we assume at least some of
them to be expressed on the ASH neurons (Ezcurra et al., 2016), but direct
expression evidence is still lacking. Dopamine receptor expression has been
shown in many other head neurons (Chase et al., 2004; Sugiura et al., 2005; Suo
et al., 2003), and that is consistent with the idea these dopamine receptors may
likely be active in other neurons to regulate this behavior. To further characterize
the sites of action, one could attempt cell specific transgenic rescue of dopamine
receptor mutants. For instance, the sra-6 promoter could be used to specifically
rescue the dopamine receptors within the ASH neuron. This approach may allow
for the understanding of which receptor is functioning in which neuron. Though
the above-mentioned experiment could be useful in understanding the possible
activity of these dopamine receptors in specific cells, it still does not describe the
natural expression patterns of the dopamine receptors.
To better understand the natural expression patterns of dopamine
receptors, our lab is currently utilizing CRISPR technology by replacing the dop-4
and dop-1 coding sequences with GFP reporter sequence in their natural
chromosomal context (L. Velasquez Macedo, in preparation). It could be
interesting to examine strains with multiple dopamine receptor mutants to
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observe possible antagonistic relationships between the various dopamine
receptor mutants. We observed that the D1-like DOP-1 and DOP-4 receptors act
to down-regulate the activity of the ASH neurons, but we have yet to experiment
with the dop-2 and dop-3 mutant strains. It is possible that the D2-like DOP-2 and
DOP-3 receptors could act to up-regulate ASH activity and so may play an
antagonistic role with the DOP-1 or DOP-4 receptors. Further examination of
these dopamine receptor mutants may provide a better understanding of the
complex regulatory roles of dopamine within sensory neural circuits.
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APPENDIX A:
FIGURES AND TABLES
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Figure 1: A circuit diagram of a group of C. elegans sensory neural circuits (A);
triangular shaped neurons represent sensory neurons, hexagonally shaped
neurons are interneurons, the neurons colored in blue are those that express one
or all dopamine (DA) receptors, and the neurons colored greens are those that
are dopaminergic in natural, that is they are cellular sites of DA production and
release. GFP reporter assay show the expression pattern of tyrosine hydroxylase
(B), a key enzyme in the pathway leading to the production of dopamine
(Caldwell and Caldwell, 2008).
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Figure 2: The amphid neurons of the C. elegans hermaphroditic animals are
located within the head just posterior to the pharyngeal pump, these neurons
(ASE, ASG, ASH, ASI, ASJ, ASK, ADF, ADL, AWA, AWB, AWC, AND AFD)
represent the primarily sensory neurons of the animal; C. elegans express
bilaterally symmetric amphid structures. There also exists a similar structure in
the posterior end of the animals known as the phasmid, which contains sensory
neurons (PHA, PHB, and PQR) as well (a). A more detailed illustration of the
amphid pore reveals the structure and ordering of the sensory neurons (b);
detailed illustrations show the structure of the amphid neurons dendritic sensilla
(c) (Adapted from and reviewed in Bargmann, 2006).
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Figure 3: ASH sensory activity is likely driven by a number of cellular receptors.
GPCRs are known to detect stimuli from the environment, in turn activating Gi
like subunits within the cell. It is also possible that the TRPV channels
themselves can be activated by external stimuli inducing a depolarization of the
cell via the cation flux through open channels (Adapted from and reviewed in
Bargmann, 2006).
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Figure 4: Genetically engineered Ca2+ sensitive calmodulin domain containing
green florescent protein (G-CaMP) reporter proteins (Nakai et al., 2001) (A) allow
for the quantification of neural activity within the C. elegans animals. The
transgenically coded G-CaMP genes are expressed specifically in the ASH
neuron (B). In regions of low Ca2+ concentrations the G-CaMP proteins fluoresce
at a low intensity; the intensity increases proportionally to match increases in
Ca2+ concentrations (C).
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Figure 5: The drop test behavioral assay consists of a micro-droplet of repellent
applied to a forward locomoting animal; responses are measured as a reversal of
locomotion within a given time frame.
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Figure 6: An image of the template used to create the spincast microfluidics chip
mask (Chronis et al., 2007). As seen, one mask contains information for the
casting of 20 microfluidics chip in a single molding. The microfluidics chips are
cut apart prior to any further processing.
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Figure 7: A diagrammatic figure of microfluidics device set-up, also pictured is an
enlarged image of the microfluidics recording chip. The tubing marked “A”
attaches to the chip at port 1; it is removed from the chip to pick up worms; this
activity is achieved by the addition of a three-way Luer lock valve (G) controlling
flow from the fluid reservoir (used to keep worm in position during recording) and
the syringe used for manipulating the worms. The tubing marked “B” attaches to
the chip at port 5; it delivers stimuli to the recording chip and is always placed to
the opposite side of the worm trap. The tubing marked “C” attaches at port 3 and
“D” attaches at port 6; tubing “C” and “D” are derived from the same fluid
reservoir but utilize an electronic switching solenoid (1)1 to alter the flow of fluids
with the recording chip provide rapid exposure and elimination of stimuli. The
tubing marked “E” attaches to the chip at port 4; it is derived from two separate
reservoirs, one containing M13 and the other the dopamine suspended in M13;
the switching solenoid (2) has been run in reverse in comparison to solenoid 1.
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Figure 8: cat-2 mutant animals respond differently than wildtype animals to water
soluble stimuli. We found significant differences to the response of WT and cat-2
dopamine deficient mutants to 0.1 mM Cu2+, 1M glycerol and 5 mM quinine.
These two strains exhibited no difference in response to either 0.1% SDS or the
M13 buffer (negative control).
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Figure 9: Exogenous dopamine restores normal behavior to cat-2 animals
stimulated with 5 mM quinine, shows no effect on the dop-1 or dop-4 animals
(data obtained by J. Jensen). Worms were tested on NGM plates that had been
treated to achieve 4 mM dopamine concentration, untreated plates and treated
plates with an M13 negative control stimuli. We found significant differences in
the untreated assays, yet no significant difference in the treated assays indicating
a significant effect on the worms’ behavior.
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Figure 10: The microfluidics rig is set up to run over the inverted fluorescent
microscope with an accompanying fluorescent dissecting microscope to enable
selection and transfer of subject animals (A). A close up of the recording rig
shows the tubing supplying the microfluidics chip with buffers and stimuli (B). The
microfluidics chip has a total of 6 ports: 3 ports for buffer flow, one for stimuli, one
for worm loading, and one for the vacuum line (C).
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Figure 11: Transient Ca2+ recordings from the ASH neuron allow for the
quantification of neural activity levels during stimulation. Data obtained during
recordings can be averaged and normalized to create activity traces (A). An
individual C. elegans animal is held in place within the microfluidics chip in such
a way as to have the rostral end of the animal exposed to the fluid streams; in
this position, the animal can be exposed to the M13 buffer (B) or to an aqueous
solution, drug or stimuli (C).
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Figure 12: Using glycerol as a stimulus we characterized the response of the
ASH neurons in both wildtype (A) and cat-2 (B) animals; bold lines are that of the
average response (n=10) and the thinner lines that of +/- the standard deviation.
We reported no significant difference in the maximum intensity of response
between the two strains (C).
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Figure 13: Dopamine (DA) renders C. elegans animals paralyzed during a SWIP
assay. However, when dopamine is suspended in M13 recording buffer this
paralysis dissipates (A). The salts found in the M13 recoding buffer disrupt the
paralyzing activity of dopamine during the SWIP assay (B) (M. Torres and J.
Kim).
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Figure 14: An illustration of the metrics measured with the obtained Ca2+
recordings. The dark green represents the measure of peak fluorescence, Δf/f is
a relative measure of the increase in fluorescence over that of the baseline
fluorescence. The red color represents the total time of response as far as the
total time that fluorescence is above baseline. The blue color shows the measure
of time from stimuli application to peak fluorescence. The black color shows the
measure of the initial slope to the response trace. Lastly, the grey trapezoid
represents the integral or the area found under the trace.
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Figure 15: ASH neuron Ca2+ changes in response to 50 mM quinine stimulation.
The red bar indicates period of stimulation (30 sec). Ca2+ response trace of (A)
wildtype animals (n=17/20; fraction of animals responding versus tested), (B) cat2 animals (n=7/20), (C) wildtype animals treated with 4 mM exogenous dopamine
(+DA) (n=13/20), (D) cat-2 animals treated with 4 mM exogenous dopamine
(n=9/20), (E) dop-1 animals (n=19/20), and (F) dop-4 animals (n=17/20).
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Figure 16: legend on following page.
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cat-2

dop-1

Figure 16: (previous page) T-test and ANOVA statistical analysis of the ASH
response to 50 mM quinine in a variety of genetic backgrounds. Dots indicate
outliers but are included in the analysis. (A) We observed a significant difference
in the peak fluorescence of the Ca2+ traces between the (n=17/20; fraction of
animals responding versus tested) wildtype and (7/20) cat-2 animals (p=0.0118).
ANOVA (α≤0.05) revealed a difference among wildtype cat-2, dop-1 and dop-4
(F<0.0001). The Tukey-Kramer method of comparison identified significant
differences between cat-2 and dop-1 animals (p=0.0003), between wildtype and
(n=17/20) dop-1 animals (p<0.0001), and between dop-1 and (n=19/20) dop-4
animals (p=0.0343). (B) We observed no statistical difference in the total time of
response of the Ca2+ traces. (C) We observed a statistical difference in the
integral of the Ca2+ traces between cat-2 animals and wildtype animals
(p=0.0162). ANOVA (α≤0.05) indicated significant differences among wildtype,
cat-2, dop-1, and dop-4 (F=0.0016). The Tukey-Kramer method of comparison
identified significant differences between cat-2 and dop-1 animals (p=0.0081),
and between wildtype animals and dop-1 animals (p=0.0064). (D) ANOVA
(α≤0.05) indicated a significant difference among wildtype, cat-2, dop-1, and dop4 (F=0.0181). The Tukey-Kramer method of comparison identified a statistical
difference in the initial slopes of the Ca2+ traces between wildtype animals and
dop-1 animals (p=0.0370). (E) ANOVA (α≤0.05) indicated significant differences
among wildtype, cat-2, dop-1, and dop-4 (F=0.0694). The Tukey-Kramer method
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of comparison identified a significant difference in time to peak fluorescence
between dop-1 and wildtype animals (p=0.0487).
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Primer
name

Sequence (5'-3')

Orientation

Strain

Notes

cat-2 #4

gcgaatgacgtcactcctatcg

sense

cat-2

cat-2 #3

gagacatatgagctagcagtgg

antisense

cat-2

left
primer for
e1112
right
primer for
e1112

oZY46

cagctctaaaacaattatggttcgt

sense

dop-1

left
primer for
vs101

oZY47

catatcttgacgagctaaatttcca

antisense

dop-1

internal
primer for
vs101

oZY48

acagaaacagatgaaaaatgagac
c

antisense

dop-1

right
primer for
vs101

oZY55

aatgttggcttacgggtctg

sense

dop-4

left
primer for
tm1392

oZY56

aaaattaggtctcggcacagc

antisense

dop-4

internal
primer
tm1392

oZY57

caaggcacgttctagtgcag

antisense

dop-4

right
primer for
tm1392

Table 1: identification of all primers used for genotyping the various mutant
strains used in this study. Primer names are specific to our lab. Sense/antisense
is relative to the target gene coding sequence.
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